Mereo BioPharma (MREO) Return on Sales (2023 - 2025)

Mereo BioPharma (MREO) has 3 years of Return on Sales data on file, last reported at 0.84% in Q4 2025.

• Return on Sales for Q4 2025 came in at 0.84%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.84% (changed N/A YoY), and the FY2025 annual result was 0.84%, changed N/A from the prior year.
• Return on Sales retreated to 0.84% in Q4 2025 per MREO's latest filing, from 0.83% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q2 2023 and troughed at 0.84% in Q4 2025.
• A 3-year average of 0.37% and a median of 0.34% in 2024 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2024 and 2025: Return on Sales tumbled 38 bps in 2024, then climbed 9 bps in 2025.
• A 3-year view of Return on Sales shows it stood at 0.1% in 2023, then sank by 356 bps to 0.46% in 2024, then tumbled by 81 bps to 0.84% in 2025.
• Business Quant data shows MREO's Return on Sales at 0.84% in Q4 2025, 0.83% in Q3 2025, and 0.29% in Q2 2025.